Healthcare & Life Sciences News and Articles

Google News – Pharmaceuticals External News

Ionis Pharmaceuticals (IONS) Gains First-Mover Advantage with FDA Approval of Rare Brain Disease Drug - Yahoo Finance

news.google.com · 04 Sep 2026

Google News – Pharmaceuticals External News

Rong Zhou Sells 3,187 Shares of Amphastar Pharmaceuticals (NASDAQ:AMPH) Stock - MarketBeat

news.google.com · 04 Sep 2026

Google News – Pharmaceuticals External News

Galmed Pharmaceuticals Ltd reports results for the quarter ended June 30 - Earnings Summary - TradingView

news.google.com · 04 Sep 2026

Google News – FDA (biotech/pharma) External News

Ionis Pharma’s drug becomes first FDA-approved treatment for rare brain disorder - KELO-AM

news.google.com · 04 Sep 2026

Google News – Pharmaceuticals External News

Cipla Announces Exclusive Partnership with Qilu Pharmaceutical for the Licensing and Supply of Biosimilar to Keytruda® (Pembrolizumab) in the US - BioSpace

news.google.com · 04 Sep 2026

Google News – Pharmaceuticals External News

Kaplan Fox Continues to Remind ARS Pharmaceuticals Inc. (NASDAQ - The National Law Review

news.google.com · 04 Sep 2026

Google News – Pharmaceuticals External News

Cipla licenses China's Qilu Pharmaceutical Keytruda biosimilar US rights - pharma.economictimes.indiatimes.com

news.google.com · 04 Sep 2026

Google News – Biopharma External News

Osivax and GC Biopharma Announce Collaboration for Next-Generation Influenza Vaccine - Global Legal Chronicle

news.google.com · 04 Sep 2026

Google News – Clinical Trials External News

Stoke Therapeutics and Biogen Present Long-Term Clinical Data that Support the Disease-Modifying Potential of Zorevunersen, an Investigational Medicine for the Treatment of Dravet Syndrome, at the 16th European Epilepsy Congress (EEC) - Biogen

news.google.com · 04 Sep 2026

Google News – Clinical Trials External News

Stoke Therapeutics and Biogen Present Long-Term Clinical - GlobeNewswire

news.google.com · 04 Sep 2026

Google News – Pharmaceuticals External News

Kaplan Fox Continues to Remind ARS Pharmaceuticals Inc. (NASDAQ: SPRY) Investors of the Lead Plaintiff Deadline on October 5, 2026 - The Globe and Mail

news.google.com · 04 Sep 2026

Google News – Pharmaceuticals External News

Mirum Pharma (NASDAQ: MIRM) exec sells 658 shares under preset plan - Stock Titan

news.google.com · 04 Sep 2026

Google News – Pharmaceuticals External News

REGN INVESTOR ALERT: Regeneron Pharmaceuticals, Inc. Investors with Substantial Losses Have Opportunity to Lead the Regeneron Class Action Lawsuit - PR Newswire

news.google.com · 04 Sep 2026

Google News – Pharmaceuticals External News

Rigel Pharmaceuticals (RIGL) CEO returns 2,424 shares to issuer - Stock Titan

news.google.com · 04 Sep 2026

Google News – Pharmaceuticals External News

Rigel Pharmaceuticals (NASDAQ: RIGL) insider now holds 50,559 shares - Stock Titan

news.google.com · 04 Sep 2026

News & Articles

The 90-Day Capability Reset for Healthcare Employers

The Decision Architecture Skill Clinical Research Teams Need

Beta Bionics’ insulin patch pump gets FDA nod

HR must set boundaries as it embraces AI notetakers, experts caution

Staff slept while patient killed at NHS mental health unit

Hong Kong parents urged to vaccinate young children amid rising summer flu cases

PEN-Plus operations manual

Human factors isn’t a checkbox: What FDA’s eSTAR requirements mean for MedTech submissions

Responsible spending starts with timely access, informed choices and more connected care

The future of talent sourcing is more than clicks

The Frontline Signal: Turning Daily Friction Into Better Healthcare Hiring

The Digital Health Interpreter: Making Technology Usable in Care

The Pitt is up for 25 Emmys - but the show's biggest fans are real-life doctors

Jury should decide if university’s hiring process was tainted by diversity goals, court rules

Running costs of vaccine damage scheme more than double amount paid to victims

CMS expands TAVR Medicare coverage to asymptomatic patients

Lakeland Community Hospital receives grant to expand rural healthcare access - alreporter.com

Stryker stock falls on slower peripheral vascular, hip sales

Campaigners hold vigil as stroke unit closes

Epidural Kit Correction: Medical Action Industries Issues Correction for Epidural Kits Containing Spectra Medical Devices Lidocaine Ampules

Ionis Pharmaceuticals (IONS) Gains First-Mover Advantage with FDA Approval of Rare Brain Disease Drug - Yahoo Finance

Rong Zhou Sells 3,187 Shares of Amphastar Pharmaceuticals (NASDAQ:AMPH) Stock - MarketBeat

Galmed Pharmaceuticals Ltd reports results for the quarter ended June 30 - Earnings Summary - TradingView

Ionis Pharma’s drug becomes first FDA-approved treatment for rare brain disorder - KELO-AM

Cipla Announces Exclusive Partnership with Qilu Pharmaceutical for the Licensing and Supply of Biosimilar to Keytruda® (Pembrolizumab) in the US - BioSpace

Kaplan Fox Continues to Remind ARS Pharmaceuticals Inc. (NASDAQ - The National Law Review

Cipla licenses China's Qilu Pharmaceutical Keytruda biosimilar US rights - pharma.economictimes.indiatimes.com

Osivax and GC Biopharma Announce Collaboration for Next-Generation Influenza Vaccine - Global Legal Chronicle

Stoke Therapeutics and Biogen Present Long-Term Clinical Data that Support the Disease-Modifying Potential of Zorevunersen, an Investigational Medicine for the Treatment of Dravet Syndrome, at the 16th European Epilepsy Congress (EEC) - Biogen

Stoke Therapeutics and Biogen Present Long-Term Clinical - GlobeNewswire

Kaplan Fox Continues to Remind ARS Pharmaceuticals Inc. (NASDAQ: SPRY) Investors of the Lead Plaintiff Deadline on October 5, 2026 - The Globe and Mail

Mirum Pharma (NASDAQ: MIRM) exec sells 658 shares under preset plan - Stock Titan

REGN INVESTOR ALERT: Regeneron Pharmaceuticals, Inc. Investors with Substantial Losses Have Opportunity to Lead the Regeneron Class Action Lawsuit - PR Newswire

Rigel Pharmaceuticals (RIGL) CEO returns 2,424 shares to issuer - Stock Titan

Rigel Pharmaceuticals (NASDAQ: RIGL) insider now holds 50,559 shares - Stock Titan